Efficacy of Xuebijing injection for the treatment of coronavirus disease 2019 via network pharmacology
Journal Title: Traditional Medicine Research - Year 2020, Vol 5, Issue 4
Abstract
Background: To evaluate the mechanism of Chinese patent drug Xuebijing (XBJ) injection in the treatment of a new coronavirus disease 2019 (COVID-19) based on network pharmacology and molecular docking technology. Methods: The TCMSP database was employed to collect and screen the active ingredients of the Chinese herb contained in the XBJ injection. The GeneCards database and STRING database were applied to collect and expand the targets of COVID-19 and compare and screen the related targets of COVID-19 by XBJ injection. Cytoscape was employed to build a network connecting Chinese medicine, compounds, targets, disease, and topology analysis was performed via the Network Analyzer to screen the key ingredients and targets. The software of Schrödinger molecular docking was used to verify the binding activity of the key ingredients of XBJ injection and the key targets of COVID-19. Metascape platform and DAVID database were utilized to conduct Gene Ontology analysis and Kyoto Encyclopedia of Genes and Genomes analysis on the key targets of COVID-19 treated by XBJ injection. Results: Eight key compounds and 15 key targets were screened and verified by molecular docking; these key compounds included luteolin, quercetin, baicalein, and kaempferol. The key targets included DPP4, AR, ESR1, CALM1, and protein kinase 1. Gene Ontology analysis involved an apoptosis and hypoxia reaction and the changes in blood vessel morphology. Kyoto Encyclopedia of Genes and Genomes analysis involved signaling pathways of hypoxia inducible factor-1, VEGF, and PI3K/AKT/NF-κB. Conclusion: The mechanism of XBJ injection when used to treat COVID-19 should be further investigated as the key compounds in XBJ regulated the expression of key targets such as protein kinase 1, VEGF-A, B-cell lymphoma-2, and TNF, which affected the COVID-19 receptors such as angiotensin-converting enzyme 2 and signaling pathways like hypoxia inducible factor-1, PI3K-Akt, and NF-κB, which alleviated the inflammation, respiratory distress, and hypoxia caused by COVID-19 infection.
Authors and Affiliations
Yu-Liang Zhang,Qian Cui,Dou Zhang,Xin Ma,Guo-Wei Zhang
Keywords
Related Articles
- EP ID EP683786
- DOI 10.12032/TMR20200507178
- Views 199
- Downloads 0
Pharmacological research progress of ursolic acid for the treatment of liver diseases
Ursolic acid is a natural pentacyclic triterpenoid with various pharmacological activities such as anti-inflammatory, hepatoprotective, antitumor, and hypoglycemic activity. This natural product is widely present in many...
Two Empirical Formula for Hemostasis
Zhixue San Jin Yin Hua (Flos Lonicerae) 75g, Sheng Di (Radix Rehmanniae Recens) 75g,Bai Ji (Rhizoma Bletillae) 75g, Ma Bo (Lasiosphaera seu Calvatia) 75g, Er Cha (Catechu) 37g, Xue Jie (Sanguis Draconis)37g, Xue Yu Tan (...
The effects of nutritional ketosis induced by Bigu-herbs regimen and ketogenic diet on diseases and aging
The Bigu-herbs regimen, a Taoism (Taoism is an ancient Chinese Taoist philosophy system) special health-preserving technique to achieve longevity through strict abstinence from food, limits the intake of grains and uses...
Network pharmacology studies on the effect of Chai-Ling decoction in coronavirus disease 2019
Background: Chai-Ling decoction (CLD), derived from a modification of Xiao-Chai-Hu (XCH) decoction and Wu-Ling-San (WLS) decoction, has been used to treat the early-stage of coronavirus disease 2019 (COVID-19). However,...
The regulation of method of tonifying Qi and activating blood circulation in the related gene expressions after spinal cord injury
The regulation of the genes including AQP4 gene, Bcl-2 gene, NF gene, Caspase gene, IL gene, NF-κB gene, TNF gene and HSP to treatment Spinal Cord Injury (SCI) by method of tonifying Qi and activating blood circulation w...